天中康元药业特聘新加坡南洋理工大学慕宇光教授及团队为首席科研团队
Tianzhong Kangyuan Pharmaceutical has specially appointed Professor Mu Yuguang and his team from Nanyang Technological University, Singapore, as the Chief Scientific Research Team.
天中康元药业集团迎来科学研发、技术创新发展重要里程碑。新加坡南洋理工大学生命科学学院顶尖AI生物医药研究团队在资深教授慕宇光带领下，与集团签署深度战略合作协议,集团聘请慕宇光教授及团队核心博士等五人为天中康元药业集团首席科研团队，集团总经理曹愚亲自颁发聘书。签约仪式在集团举行，东营市政协副主席生钦勇、东营市东营区政协副主席马献忠出席签约仪式，并参加专题合作技术研讨会。
Tianzhong Kangyuan Pharmaceutical Group Reaches Important Milestone in Scientific R&D and Technological Innovation In a significant advancement for scientific research and technological innovation, Tianzhong Kangyuan Pharmaceutical Group has officially signed an in-depth strategic cooperation agreement with a top-tier AI biomedical research team from the School of Life Sciences at Nanyang University of Singapore. The agreement was formalized under the leadership of renowned senior Professor Mu Yuguang. Additionally, the Group has appointed Professor Mu Yuguang and five core Ph.D. members of his team as the Chief Scientific Research Team of Tianzhong Kangyuan Pharmaceutical Group. General Manager Cao Yu personally presented the letters of appointment. The signing ceremony was held at the Group's headquarters, with Sheng Qinyong, Vice Chairman of the Dongying Municipal Chinese People's Political Consultative Conference (CPPCC), and Ma Xianzhong, Vice Chairman of the Dongying District CPPCC, in attendance. Both leaders also participated in a specialized technical seminar on the collaboration.
此次合作的核心在于尖端生物技术与AI人工智能的深度融合，聚焦两大前沿方向：
The core of this collaboration lies in the deep integration of cutting-edge biotechnology and AI artificial intelligence, focusing on two key frontier directions:
一、AI智能微生物发酵活性提取生产工艺技术，利用AI智能算法深度优化微生物发酵过程，显著提升目标产物的产量、纯度、稳定性及靶向功效性，并通过AI优化菌种筛选与培养参数，提升活性物质产率、品质、人体吸收率、作用率，为后续研发奠定高效、可控的原料基础。
1. AI-Enabled Microbial Fermentation and Bio-active Extraction Technology By leveraging AI algorithms to deeply optimize microbial fermentation processes, the partnership aims to significantly enhance the yield, purity, stability, and targeted efficacy of bio-active compounds. AI will also be applied to improve strain selection and cultivation parameters, boosting the yield of active substances, quality, human absorption rates, and functional effectiveness. This will establish a highly efficient and controllable raw material foundation for future R&D.
二、大健康产品的功效性研究及产品创新开发，双方将利用AI智能发酵高活性原料与AI人体模型的分析与优化，重点攻关对人体具有靶向功效的领域，如免疫系统增强、保护肝功能潜力、人体代谢脂肪消耗、抑制黑色素过度生成、减少黑斑形成等健康领域的深度合作。
2. Functional Research and Innovative Product Development in Health & Wellness Utilizing AI-optimized high-activity fermentation ingredients and AI-driven human modeling, the two parties will focus on targeted health benefits, including immune system enhancement, liver function protection, metabolic fat reduction, inhibition of excessive melanin production, and reduction of dark spot formation.
副主席生钦勇高度评价了此次校企合作的前瞻性与战略意义。他指出，融合高校的源头创新能力和企业的产业化优势，尤其是在AI智能赋能生物制造这一关键赛道上发力，完全契合我市打造具有国际竞争力生物医药产业集群的战略目标。期待合作早日结出丰硕成果，惠及民生健康。
Sheng Qinyong, Vice Chairman of the Municipal CPPCC, highly praised the forward-looking and strategic significance of this university-enterprise collaboration. He emphasized that combining academia’s pioneering innovation capabilities with industry’s commercialization strengths—particularly in the critical field of AI-powered bio-manufacturing—fully aligns with the city’s strategic goal of building a globally competitive bio-pharmaceutical industry cluster. He expressed hope for early breakthroughs that would benefit public health.
慕宇光教授在研讨会上阐释了合作愿景：“AI在微生物世界的‘精耕细作’，将极大释放生物合成的潜力，解决传统工艺的瓶颈。我们与企业携手，就是要打通从实验室发现到规模化生产的‘最后一公里’，让尖端科研成果更快、更好地转化为守护大众健康的实际产品，特别是在药食同源生物制剂领域。”
Professor Mu Yuguang Unveils Collaborative Vision at Seminar： During the symposium, Professor Mu Yuguang elaborated on the partnership’s vision: "AI’s 'precision cultivation' in the microbial world will unlock the full potential of bio-synthetic processes, overcoming bottlenecks in traditional methods. By joining forces with industry, we aim to bridge the 'last mile' from laboratory discovery to scaled production—ensuring cutting-edge scientific achievements are swiftly and effectively translated into tangible health solutions for the public, particularly in the realm of medicinal-food homologous bio-formulations
研讨会期间。双方还就"知识产权入股""临床机构参与功效验证"等创新合作机制达成共识，推动实验室技术向"治疗级原料生产、疗效型产品开发"跨越。
During the seminar, the two sides also reached consensus on innovative cooperation mechanisms such as "intellectual property equity participation" and "clinical institutions participating in efficacy verification", promoting the leap of laboratory technology to "production of therapeutic grade raw materials and development of therapeutic products".
集团总经理曹愚表示，此次强强联合是公司布局AI+生物科技战略的关键落子，将依托南洋理工大学生命科学学院慕宇光教授团队强大的科研实力，加速自有技术平台的升级迭代，共同开发具有全球市场竞争力的新一代大健康产品。
Cao Yu, general manager of the group, said that this strong alliance is a key move in the company's AI+ biotechnology strategy. It will rely on the strong scientific research strength of Professor Mu Yuguang's team from the School of Life Sciences, Nanyang Technological University to accelerate the upgrade and iteration of its own technology platform and jointly develop a new generation of health products with global market competitiveness.
集团首期将投入5000万元共建联合实验室及AI模型，预计二年内实现至少一项核心技术产业化，AI+生物科技为集团破解健康领域关键难题提供了创新路径，其成果有望在未来深刻影响集团公司各类生物原料、中药、保健食品、功能性食品、营养补充剂等领域的市场，此次合作标志着集团发展新质生产力及产、学、研协同创新迈出坚实一步。
The group plans to invest 50 million yuan in the first phase to establish a joint laboratory and develop AI models. It is expected that at least one core technology will be industrialized within two years. AI + biotechnology offers an innovative approach for the group to tackle key challenges in the health sector. The outcomes of this collaboration are expected to significantly impact the market for various biological raw materials, traditional Chinese medicine, health foods, functional foods, and nutritional supplements of the group in the future. This partnership marks a significant step forward in the group's efforts to develop new productive forces and promote collaborative innovation among industry, academia, and research.
天中康元—追求绿色天然 创造健康人生。
Tianzhong Kangyuan Pursuing Green Live Healthy.
